Sep 30,2021

One Drop Joins the American Heart Association’s Innovators’ Network at the Center for Health Technology & Innovation

One Drop, a provider of precision health solutions for people living with chronic conditions, has joined the American Heart Association Center for Health Technology & Innovation (the Center) Innovators’ Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions across the health continuum.

View Analyst & Ambassador Comments
Go to original news
Sep 30,2021

Insulet’s Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycemic Control With One Year of Use

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, has presented positive pivotal trial extension phase results for the Omnipod® 5 Automated Insulin Delivery System (Omnipod 5). Omnipod 5, the world’s first tubeless, wearable system that continuously adapts insulin delivery based on glucose levels and trends, significantly improved time in range and reduced HbA1c in children, adolescents, and adults, aged 6-70 years, with type 1 diabetes over a period of 12 months. The data was presented at EASD 2021, the annual meeting of the European Association for the Study of Diabetes.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Oct 26,2021

Digital health pioneer closes Series A funding round and attracts new investors

HelloBetter raises six million Euros to build the category leader in digital mental health. HelloBetter, a global leader in the field of e-mental health innovation, has closed a Series A funding round of …

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Oct 28,2021

Rimidi Achieves 2021 Net Promoter Score (NPS) of 70, Putting Company in the 100th Percentile for the Software industry

The score puts Rimidi over 30 points higher than the average healthcare company, and in the 100th percentile of the Software industry. The result underscores that Rimidi's innovative approach to clinical decision support and enabling personalized management of health conditions by connecting disparate data drives significant customer value and return on investment.

View Analyst & Ambassador Comments
Go to original news
Oct 01,2021

Gini Health Debuts Into Chronic Health Care Management, Launches Diabetes Reversal Program

Gini Health, one of North America’s fastest growing health-tech companies, has teamed up with world-class doctors to launch a type 2 diabetes reversal program. Riding on the success of its pilot 12-week diabetes reversal program, conducted with participants from South Asian diaspora, Gini Health announced that it has debuted into chronic health care management.

PRODUCT

#product & service

View Analyst & Ambassador Comments
Go to original news
Oct 01,2021

Impact of government-funded insulin pump programs on insulin pump use in Canada: a cross-sectional study using the National Diabetes Repository

Introduction Insulin pump access in type 1 diabetes may be inequitable. We studied the association between government funding programs for insulin pumps and rates of insulin pump use and disparities between pump users and non-users.

CLINICAL STUDY

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Oct 04,2021

BD To Announce Fiscal 2021 Fourth Quarter And Full Year Financial Results

BD announced today that it will report its fiscal 2021 fourth quarter and full year financial results on Thursday, Nov. 4, 2021. BD will issue a press release detailing the quarter's results, along with related presentation materials posted to www.bd.com/investors, at approximately 6 a.m. Eastern Time (ET).

View Analyst & Ambassador Comments
Go to original news
Oct 04,2021

GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor

GraphWear, a company pursuing needle-free approaches to glucose monitoring, has closed a $20.5 million Series B round. This Series B round is a vote of confidence by investors in GraphWear’s approach: to monitor key metrics in the body, like glucose, without breaking the skin at all.

FUNDING SERIES B

#rpm

View Analyst & Ambassador Comments
Go to original news
Oct 06,2021

Teladoc Health Reimagines Primary Care with Primary360

Teladoc Health, the global leader in whole-person virtual care, today announced that its primary care service, Primary360, is now available to commercial health plans, employers and other organizations that sponsor health care for individuals and families in the United States. Access to high quality prevention and screening via Primary360 has helped members detect earlier and treat previously undiagnosed chronic diseases. Early results with year one members show one in four chronic conditions identified for Primary360 members have been new diagnoses of common disorders such as diabetes and hypertension.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
Oct 07,2021

Tandem Diabetes Care to Announce Third Quarter 2021 Financial Results on November 3, 2021

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, plans to release its third quarter 2021 results after the financial markets close on Wednesday, November 3, 2021. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2021 financial and operating results.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES